Omada Health (NASDAQ:OMDA) CAO Sells $41,680.00 in Stock

by · The Cerbat Gem

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 2,084 shares of the firm’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $20.00, for a total value of $41,680.00. Following the transaction, the chief accounting officer owned 2,941 shares of the company’s stock, valued at $58,820. The trade was a 41.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Craig Gracey also recently made the following trade(s):

  • On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total value of $43,743.00.
  • On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total transaction of $39,597.83.
  • On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00.
  • On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Up 1.3%

Omada Health stock traded up $0.28 during trading hours on Tuesday, hitting $21.95. The stock had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. The stock’s 50-day moving average price is $16.83 and its 200-day moving average price is $14.93. The stock has a market capitalization of $1.30 billion and a P/E ratio of -81.30. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92.

Omada Health (NASDAQ:OMDA – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, research analysts expect that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Needham & Company LLC restated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. Evercore reaffirmed an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Citizens Jmp upped their target price on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research note on Friday, May 8th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $22.91.

Check Out Our Latest Report on Omada Health

Institutional Trading of Omada Health

Hedge funds have recently bought and sold shares of the stock. Quarry LP purchased a new stake in Omada Health in the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health during the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. bought a new position in shares of Omada Health in the second quarter worth approximately $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health in the fourth quarter worth approximately $45,000. Finally, Strs Ohio increased its stake in shares of Omada Health by 151.0% in the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after purchasing an additional 2,567 shares in the last quarter.

Omada Health Company Profile

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Read More